Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPancras C.W. Hogendoorn, D. Vanel, Nick Athanasou et al.|Annals of Oncology|2010Cited by 718
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa Marina, Lisa A. Teot, Sigbjørn Smeland et al.|The Lancet Oncology|2016Cited by 537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan Bielack, Mark L. Bernstein, Sigbjørn Smeland et al.|Journal of Clinical Oncology|2015Cited by 419
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study GroupToshifumi Ozaki, Stefan Bielack, Silke Flege et al.|Journal of Clinical Oncology|2003Cited by 343